Abstract:Abstract Background Variation in intercellular methylation patterns can complicate the use of methylation biomarkers for clinical diagnostic applications such as blood-based cancer testing. Here, we describe development and validation of a methylation density binary classification method called EpiClass (available for download at https://github.com/Elnitskilab/EpiClass ), that can be used to predict and optimize the performance of methylation biomarkers, particularly in challenging, heterogeneous samples such as liquid biopsies. This approach is based upon leveraging statistical differences in single-molecule sample methylation density distributions to identify ideal thresholds for sample classification. Results We developed and tested the classifier using reduced representation bisulfite sequencing (RRBS) data derived from ovarian carcinoma tissue DNA and controls. We used these data to perform in silico simulations using methylation density profiles from individual epiallelic copies of ZNF154 , a genomic locus known to be recurrently methylated in numerous cancer types. From these profiles, we predicted the performance of the classifier in liquid biopsies for the detection of epithelial ovarian carcinomas (EOC). In silico analysis indicated that EpiClass could be leveraged to better identify cancer-positive liquid biopsy samples by implementing precise thresholds with respect to methylation density profiles derived from circulating cell-free DNA (cfDNA) analysis. These predictions were confirmed experimentally using DREAMing to perform digital methylation density analysis on a cohort of low volume (1-mL) plasma samples obtained from 26 EOC-positive and 41 cancer-free women. EpiClass performance was then validated in an independent cohort of 24 plasma specimens, derived from a longitudinal study of 8 EOC-positive women, and 12 plasma specimens derived from 12 healthy women, respectively, attaining a sensitivity/specificity of 91.7%/100.0%. Direct comparison of CA-125 measurements with EpiClass demonstrated that EpiClass was able to better identify EOC-positive women than standard CA-125 assessment. Finally, we used independent whole genome bisulfite sequencing (WGBS) datasets to demonstrate that EpiClass can also identify other cancer types as well or better than alternative methylation-based classifiers. Conclusions Our results indicate that assessment of intramolecular methylation density distributions calculated from cfDNA facilitate the use of methylation biomarkers for diagnostic applications. Furthermore, we demonstrated that EpiClass analysis of ZNF154 methylation was able to outperform CA-125 in the detection of etiologically-diverse ovarian carcinomas, indicating the broad utility of ZNF154 for use as a biomarker of ovarian cancer.

A supervised learning method for classifying methylation disorders

Diagnostic classification based on DNA methylation profiles using sequential machine learning approaches.

Machine-learning operations streamlined clinical workflows of DNA methylation-based CNS tumor classification.

A Novel Computational Method For Detecting Dna Methylation Sites With Dna Sequence Information And Physicochemical Properties

Comprehensive study of semi-supervised learning for DNA methylation-based supervised classification of central nervous system tumors

DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer.

Classification of Schizophrenia Patients According to DNA Methylation Data Based on Meta-learning

The Progress on the Estimation of DNA Methylation Level and the Detection of Abnormal Methylation

A novel method for detecting association between DNA methylation and diseases using spatial information

Microarray-Based DNA Methylation Profiling

A new parsimonious method for classifying Cancer Tissue-of-Origin Based on DNA Methylation 450K data

Use of DNA Methylation for Cancer Detection and Molecular Classification

DNA methylation-based classification of malformations of cortical development in the human brain

Improving the clinical performance of blood-based DNA methylation biomarkers utilizing locus-specific epigenetic heterogeneity

A machine learning-based method for feature reduction of methylation data for the classification of cancer tissue origin

A Classification Approach for DNA Methylation Profiling with Bisulfite Next-Generation Sequencing Data

DNA methylation markers in the diagnosis and prognosis of common leukemias

A comprehensive comparison of residue-level methylation levels with the regression-based gene-level methylation estimations by ReGear

Application of the Rank-Based Method to DNA Methylation for Cancer Diagnosis.

Identification of Differentially Methylated Sites with Weak Methylation Effects.

A hybrid metaheuristic-deep learning technique for the pan-classification of cancer based on DNA methylation